Rating History for Axsome Therapeutics (AXSM) by BMO Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/20/2026 Malcolm Hoffman New Coverage Outperform
(N/A)
310.00
(N/A)
230.00
(239.62)
4.18% Details